IDEXX Laboratories Inc. (Nasdaq: IDXX) has developed a diagnostic test to help veterinarians detect kidney injury in cats and dogs at an earlier stage to improve treatment. The Westbrook-based ...
Cancer Dx Panel expansion and inVue Dx FNA cytology rollout advance veterinary cancer care, enabling comprehensive mast cell ...
The launch of the Catalyst® Pancreatic Lipase Test demonstrates IDEXX's Technology for Life strategy and will provide veterinarians with quantitative results at the point-of-care in less than 10 ...
The Catalyst Cortisol Test will be available in the U.S. and Canada at the end of July 2025, with a global rollout to the installed base of more than 75,000 Catalyst chemistry analyzers expected to ...
Hosted on MSN
IDEXX Laboratories Shares Surge 7% After Beating Q3 Estimates on Strong Diagnostic Demand
IDEXX Laboratories (NASDAQ:IDXX) shares jumped 7.2% on Monday after the animal health diagnostics leader reported third-quarter earnings and revenue that topped Wall Street expectations, supported by ...
May 1 (Reuters) - Animal diagnostics maker IDEXX Laboratories (IDXX.O), opens new tab on Thursday raised its annual profit forecast after it beat Wall Street estimates for quarterly profit, as it ...
On January 13, 2026, IDEXX Laboratories announced that Michael (Mike) Erickson, PhD, will become President and CEO on May 12, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback